About: Neal S. Kleiman

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neal S. Kleiman Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
field of work	wds:Q112157008-1F8B8775-FC33-4D85-A4CA-F81D5C3C98E5 wds:Q112157008-871EC010-0B8D-41CF-B70B-00434277BA0C wds:Q112157008-A3706E87-9334-4187-AB48-821AA941D8BE wds:Q112157008-AF5468A8-598D-4594-92E3-BF9143D88763 wds:Q112157008-C4EE855D-7BD2-4D85-9908-DBB92D299F2F wds:Q112157008-DFCC2586-4260-4AF9-BF42-4050180197BF wds:Q112157008-E2B97D81-6CD7-4A21-AF26-6FBD5858970D
field of work	blood coagulation coronary artery cardiology cardiovascular disease angioplasty stent interventional cardiology
description	Lékař, kardiolog, vysokoškolský pedagog a výzkumný pracovní. Zaměřuje se na strukturální onemocnění srdce, angioplastiku, stentování, onemocnění věnčitých tepen a intervenční kardiologii. Ve výzkumu se zabývá vztahy mezi angioplastikou, stentováním a (cs)
rdfs:label	Neal S. Kleiman (cs) Neal S. Kleiman (de) Neal S. Kleiman (en)
skos:prefLabel	Neal S. Kleiman (cs) Neal S. Kleiman (de) Neal S. Kleiman (en)
name	Neal S. Kleiman (cs) Neal S. Kleiman (de) Neal S. Kleiman (en)
instance of	wds:Q112157008-1AE5C05B-21EB-4CE4-A4A8-2E981C48E23C
NL CR AUT ID	wds:Q112157008-1D5DAA80-4FFA-4C5C-8BCC-5D59C0866999
instance of	Homo sapiens
NL CR AUT ID	ntk20221154241
occupation	wds:Q112157008-1D61E962-4DFC-4A9A-B903-A7A8B76EAC3B wds:Q112157008-6c5eea20-1ebd-4926-b00b-e54fff846eef wds:Q112157008-7d05a98e-93e2-4450-b9ee-b84471ca70d5 wds:Q112157008-e7820e6f-efbc-4ab9-874d-88dfe69595b2
languages spoken, written or signed	wds:Q112157008-7fb7111e-e44d-4355-83d6-5666639a131e
sex or gender	wds:Q112157008-38478DD2-7334-4A34-87A3-CA1B32E110B4
ISNI	wds:Q112157008-028188ad-1bf3-47ea-8372-1e022b4604d9
VIAF ID	wds:Q112157008-87CB198C-BC9F-4DE8-9C17-47C39AC71712
IdRef ID	wds:Q112157008-a47a19de-c941-4119-81ee-3aa9ee24a6d5
National Library of Israel J9U ID	wds:Q112157008-CF047113-3F85-44A1-BDF0-1D5D6EDA2BD7
VIAF ID	http://viaf.org/viaf/315210413
IdRef ID	http://www.idref.fr/227180879/id
occupation	university teacher scientist physician cardiologist
languages spoken, written or signed	English
sex or gender	male
ISNI	0000000353497973
VIAF ID	315210413
IdRef ID	227180879
National Library of Israel J9U ID	987007362473005171
is owl:sameAs of	Neal S. Kleiman
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q112157008
is author of	Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic even Platelet inhibition with cangrelor in patients undergoing PCI. Systematic adjudication of myocardial infarction end-points in an international clinical trial Troponin criteria for myocardial infarction after percutaneous coronary intervention. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of ≥70 years Transcatheter aortic-valve replacement with a self-expanding prosthesis Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial Intravenous platelet blockade with cangrelor during PCI. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement Association of immature platelets with adverse cardiovascular outcomes Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease Red cell distribution width as a bleeding predictor after percutaneous coronary intervention. Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease Bleeding Risk Comparing Targeted Low-Dose Heparin With Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery Mode of death after contemporary percutaneous coronary intervention: a report from the Evaluation of Drug Eluting Stents and Ischemic Events registry Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity Combining antiplatelet and anticoagulant therapies Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software